No black box warning on record for Gleolan

As of the latest FDA labeling reviewed, Gleolan (AMINOLEVULINIC ACID HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Gleolan medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Phototoxic reactions: Do not administer phototoxic drugs (St. John's wort, griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulphonamides, quinolones and tetracyclines), and topical preparations containing ALA for 24 hours during the perioperative period. Reduce exposure to sunlight or room lights for 48 hours after oral administration of Gleolan. ( 5.1 ,

No black box warning on record for Gleolan

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Phototoxic reactions: Do not administer phototoxic drugs (St. John's wort, griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulphonamides, quinolones and tetracyclines), and topical preparations containing ALA for 24 hours during the perioperative period. Reduce exposure to sunlight or room lights for 48 hours after oral administration of Gleolan. ( 5.1 ,

Gleolan Black Box Warning

No black box warning on record for Gleolan

Other warnings & precautions

Gleolan Black Box Warning

No black box warning on record for Gleolan

Other warnings & precautions